Breast Cancer Trial, Recruiting NCT05386628 Sponsor: Istanbul Medeniyet University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05386628
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between the ages of 30 and 60
  • You have had breast surgery within the last 2 years
  • You have not received any physical therapy or rehabilitation treatment for your shoulder in the last 6 months
  • You have limited movement in your shoulder as a result of your breast surgery

Who may not be able to join:

  • You have not agreed to take part in the study
  • You have had a full (radical) mastectomy, which removes the entire breast along with surrounding tissue
  • You have a connective tissue disease (a condition affecting the tissues that support and connect parts of the body — confirm with trial site)
  • You have weakness or loss of movement in your arm caused by nerve damage near the shoulder (brachial plexus injury — confirm with trial site)
  • You have scarring or hardening of tissue caused by radiation treatment (confirm with trial site)
  • You have other bone, nerve, or joint conditions that affect how your arm or shoulder works, such as scoliosis, multiple sclerosis, stroke, rheumatoid arthritis, or similar conditions
  • You have cancer that has spread (active metastases) to other parts of your body
  • You have had breast reconstruction surgery
  • You are currently receiving radiotherapy (it must have ended at least 3 months ago) or are still undergoing chemotherapy
  • You have had surgery on both breasts (bilateral mastectomy)
  • You have developed swelling in your arm or chest area caused by fluid build-up (lymphedema)
  • You are currently taking muscle relaxant medications
  • You are experiencing severe side effects from chemotherapy, such as increased skin sensitivity, nausea, skin changes, or significant weakness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905067638556

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Medeniyet University
Registry
ClinicalTrials.gov
Start date
15 August 2022
Est. completion
15 June 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

measurement of tissue stiffness (N/m); measurement of passive muscle tone (Hz); measurement of creep of tissue; measurement of the range of shoulder joint motion; assessment of activity of daily living; assessment of depression and anxiety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov